Bristol-Myers Squibb (BMY) Tops Q1 EPS by 8c

Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $2.05, $0.08 better than the analyst estimate of $1.97. Revenue for the quarter came in at $11.3 billion versus the consensus estimate of $11.49 billion.

GUIDANCE:

Bristol-Myers Squibb sees FY2023 EPS of $7.95-$8.25, versus the consensus of $8.04.

For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M